Literature DB >> 17289664

O-linked N-acetylglucosaminylation is involved in the Ca2+ activation properties of rat skeletal muscle.

Julie Hedou1, Caroline Cieniewski-Bernard, Yves Leroy, Jean-Claude Michalski, Yvonne Mounier, Bruno Bastide.   

Abstract

O-Linked N-acetylglucosaminylation termed O-GlcNAc is a dynamic cytosolic and nuclear glycosylation that is dependent both on glucose flow through the hexosamine biosynthesis pathway and on phosphorylation because of the existence of a balance between phosphorylation and O-GlcNAc. This glycosylation is a ubiquitous post-translational modification, which probably plays an important role in many aspects of protein functions. We have previously reported that, in skeletal muscle, proteins of the glycolytic pathway, energetic metabolism, and contractile proteins were O-GlcNAc-modified and that O-Glc-NAc variations could control the muscle protein homeostasis and be implicated in the regulation of muscular atrophy. In this paper, we report O-N-acetylglucosaminylation of a number of key contractile proteins (i.e. myosin heavy and light chains and actin), which suggests that this glycosylation could be involved in skeletal muscle contraction. Moreover, our results showed that incubation of skeletal muscle skinned fibers in N-acetyl-d-glucosamine, in a concentration solution known to inhibit O-GlcNAc-dependent interactions, induced a decrease in calcium sensitivity and affinity of muscular fibers, whereas the cooperativity of the thin filament proteins was not modified. Thus, our results suggest that O-GlcNAc is involved in contractile protein interactions and could thereby modulate muscle contraction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289664     DOI: 10.1074/jbc.M606787200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway.

Authors:  Victor V Lima; Fernanda R Giachini; Fernando S Carneiro; Maria Helena C Carvalho; Zuleica B Fortes; R Clinton Webb; Rita C Tostes
Journal:  Cardiovasc Res       Date:  2010-10-26       Impact factor: 10.787

2.  A novel, in-solution separation of endogenous cardiac sarcomeric proteins and identification of distinct charged variants of regulatory light chain.

Authors:  Sarah B Scruggs; Rick Reisdorph; Mike L Armstrong; Chad M Warren; Nichole Reisdorph; R John Solaro; Peter M Buttrick
Journal:  Mol Cell Proteomics       Date:  2010-05-05       Impact factor: 5.911

Review 3.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

4.  O-GlcNAcylation and phosphorylation of β-actin Ser199 in diabetic nephropathy.

Authors:  Yoshihiro Akimoto; Kunimasa Yan; Yuri Miura; Hiroki Tsumoto; Tosifusa Toda; Toshiyuki Fukutomi; Daisuke Sugahara; Akihiko Kudo; Tomio Arai; Yuko Chiba; Shinya Kaname; Gerald W Hart; Tamao Endo; Hayato Kawakami
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-30

5.  O-GlcNAcylation of AMPA receptor GluA2 is associated with a novel form of long-term depression at hippocampal synapses.

Authors:  Erica W Taylor; Kai Wang; Amy R Nelson; Teruko M Bredemann; Kyle B Fraser; Sarah M Clinton; Rosemary Puckett; Richard B Marchase; John C Chatham; Lori L McMahon
Journal:  J Neurosci       Date:  2014-01-01       Impact factor: 6.167

6.  Muscle-specific overexpression of NCOATGK, splice variant of O-GlcNAcase, induces skeletal muscle atrophy.

Authors:  Ping Huang; Shiuh-Rong Ho; Kai Wang; Bryan C Roessler; Fengxue Zhang; Yong Hu; Damon B Bowe; Jeffrey E Kudlow; Andrew J Paterson
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-22       Impact factor: 4.249

Review 7.  O-GlcNAcylation, an original modulator of contractile activity in striated muscle.

Authors:  C Cieniewski-Bernard; V Montel; L Stevens; B Bastide
Journal:  J Muscle Res Cell Motil       Date:  2010-02-25       Impact factor: 2.698

8.  Localization of O-GlcNAc-modified proteins in neuromuscular diseases.

Authors:  Seika Nakamura; Satoshi Nakano; Makoto Nishii; Satoshi Kaneko; Hirofumi Kusaka
Journal:  Med Mol Morphol       Date:  2012-06-21       Impact factor: 2.309

9.  O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function.

Authors:  Genaro A Ramirez-Correa; Wenhai Jin; Zihao Wang; Xin Zhong; Wei Dong Gao; Wagner B Dias; Cecilia Vecoli; Gerald W Hart; Anne M Murphy
Journal:  Circ Res       Date:  2008-11-06       Impact factor: 17.367

10.  O-linked beta-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins.

Authors:  Win D Cheung; Kaoru Sakabe; Michael P Housley; Wagner B Dias; Gerald W Hart
Journal:  J Biol Chem       Date:  2008-10-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.